T1D exchange quality improvement collaborative: Accelerating change through benchmarking and improvement science for people with type 1 diabetes

INTRODUCTION

Since the discovery of insulin 100 years ago, there have been continual advances in medications and technologies for the management of type 1 diabetes (T1D). Despite these innovations, many people struggle to meet hemoglobin A1c (HbA1c) goals, and the gap is larger in individuals from minority groups¹ or lower socioeconomic status. Quality improvement (QI) efforts have been shown to improve outcomes for patients with T1D.² The T1D Exchange Quality Improvement Collaborative (T1DX-QI) was established in 2016 with 10 pilot centers, primarily consisting of pediatric sites.^3, 4 The collaborative has now grown to 41 participating centers (28 pediatric and 13 adult centers) across the United States (Figure 1).

https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13234